Related Experiment Video
Updated: Aug 20, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab
Jason A Zell1, Eugene J Yoon, S-H Ignatius Ou
1Division of Hematology/Oncology, Department of Medicine, College of Medicine, University of California Irvine, Irvine, CA, USA. jzell@uci.edu
Abstract:
A patient with stage IV non-Hodgkin's lymphoma and chronic hepatitis who was treated with chemotherapy and rituximab developed fatal reactivation of hepatitis B. High viral load titers of hepatitis B DNA were demonstrated. DNA sequencing analysis revealed the presence of the precore mutant strain. Hepatitis B reactivation in patients receiving rituxmab-based chemotherapy is reviewed and the role of precore mutant virus strains resulting in fatal complications is discussed.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Hypersensitivity Reactions: Cytolytic Reactions
Treatment Resistent Cancers
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
